AI gen Koala judge
Adobe Stock
The Market Online - At The Bell

Join our daily newsletter At The Bell to receive exclusive market insights

A disappointing day for Silver Mines’ (ASX:SVL) shareholders was exemplified in a 10% sell off in afternoon trades as an environmental group’s challenge to its Bowdens Silver Project (BSP) gathers steam.

The Court of Appeal today upheld an appeal launched against Silver Mines by the Bingman Catchment Landcare Group (BCLG) relating to a prior dismissal.

The BCLG had formerly taken Silver Mines to court in the NSW land court; a judge there dismissed the former’s claim, but now BCLG’s challenge has been ratified by the Court of Appeal decision.

All in all, Silver Mines stated on Friday it was now talking to counsel and considering whether or not to start application documentation anew.

The BCLG’s claim focused heavily on the impacts a proposed transmission line to site would cause environmental assets in the area.

However, the group is really more worried about the threat of lead contamination, per former media outreach BCLG has conducted.

Much environmental law in Australia of this ‘activist’ type hinges on administrative law, which ultimately boils down to finding errors in paperwork and other technicalities.

That the NSW planning commission failed to consider the ramifications of a transmission line is a fairly good example of that type of strategy in action.

SVL last traded at

SVL by the numbers
More From The Market Online
Market Close Graphic

ASX Market Close: Another reversal as just-green Oz markets ignore US dive | Jan 3, 2024

The Aussie bourse has defied morning expectations for the second time in as many days, closing out all but flat with a 0.
A Red Sky Energy rig out in the ocean.

Red Sky Energy bleeds more than 18% after ‘landmark’ Angola block entry

Red Sky Energy was ready to pop champagne after being awarded 35% in a "transformative" Angola…
A patient being dosed with Imugene Limited testing materials.

First Aussie doses bring Imugene major step closer to ‘quicker, cheaper’ non-Hodgkin’s lymphoma care

Imugene Limited (ASX:IMU) has hit its first important milestone in 2025, dosing its first Australian patient with its allogenic
A market trading board with ASX marked on the side.

‘Shine a light’: ASX to get more aggressive on companies ‘not up to scratch’ on disclosures

The Australian Securities Exchange (ASX:ASX) will be taking poor disclosure from market-listed companies far more seriously through this next